The Goldman Sachs Group Issues Pessimistic Forecast for Iovance Biotherapeutics (NASDAQ:IOVA) Stock Price
Iovance Biotherapeutics (NASDAQ:IOVA – Get Free Report) had its target price lowered by analysts at The Goldman Sachs Group from $18.00 to $16.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The brokerage currently has a “buy” rating on the biotechnology company’s stock. The Goldman Sachs Group’s target price would indicate […]
Iovance Biotherapeutics (NASDAQ:IOVA – Get Free Report) had its target price lowered by analysts at The Goldman Sachs Group from $18.00 to $16.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The brokerage currently has a “buy” rating on the biotechnology company’s stock. The Goldman Sachs Group’s target price would indicate […]